Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps with early hair regrowth in people with alopecia areata.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Topical cyclosporin-A is recommended for severe alopecia areata.

Triamcinolone acetonide and betamethasone 1.75 mg/ml are both effective for treating alopecia areata.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Topical 1% pimecrolimus effectively treated alopecia areata.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Ritlecitinib is safe and may effectively treat alopecia areata.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Weekly Azathioprine Pulse therapy is more effective than Betamethasone Oral Mini-Pulse for hair regrowth in moderate to severe Alopecia Areata.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Azathioprine may be an effective treatment for severe hair loss.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.